Epicorynoxidine

CAS No. 58000-48-9

Epicorynoxidine( —— )

Catalog No. M29137 CAS No. 58000-48-9

Epicorynoxidine is an alkaloid derived from the herbs of Corydalis tashiroi.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 447 Get Quote
5MG 773 Get Quote
10MG 1031 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Epicorynoxidine
  • Note
    Research use only, not for human use.
  • Brief Description
    Epicorynoxidine is an alkaloid derived from the herbs of Corydalis tashiroi.
  • Description
    Epicorynoxidine is an alkaloid derived from the herbs of Corydalis tashiroi.(In Vitro):Epicorynoxidine shows cytotoxicity of P-388 cell lines with ED50 of 25.53 μg/mL.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    58000-48-9
  • Formula Weight
    371.433
  • Molecular Formula
    C21H25NO5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1cc2CC[N@+]3([O-])Cc4c(C[C@H]3c2cc1OC)ccc(OC)c4OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Narchinol B

    Narchinol B (Compound 4) is a sesquiter penoid compound. Narchinol B has anti-inflammatory effects. Narchinol B works by inhibiting proinflammatory mediators, including prostaglandin E2 (PGE2), inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) proteins,as well as proinflammatory cytokines, such as interleukin-1b, IL-6, and tumor necrosis factor-α (TNF-α). Narchinol B significantly inhibits LPS-induced overproduction of NO in BV2 cells (IC50=2.43 μM).

  • petunidin-3-O-(6-O-p...

    petunidin-3-O-(6"-O-p-coumaroyl)glucoside-5-O-diglucoside

  • Dextrothyroxine

    Dextrothyroxine could lower cholesterol and also increases hepatic lipase which in turn improves utilization of triglycerides, leading to improve apolipoprotein E cholesterol particles.